SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-006782
Filing Date
2020-01-14
Accepted
2020-01-14 08:13:32
Documents
3
Period of Report
2020-01-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d868033d8k.htm 8-K 20987
2 EX-99.1 d868033dex991.htm EX-99.1 13308
3 GRAPHIC g868033g0113220627871.jpg GRAPHIC 3160
  Complete submission text file 0001193125-20-006782.txt   40247
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 20525013
SIC: 2834 Pharmaceutical Preparations